Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05001750 · ClinicalTrials.gov registry record · Phase 1
Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
A Phase 1 study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT05001750 is a Phase 1 study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 84 participants, below the 1,173-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05001750, a Phase 1 study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The principal objective of this study is to compare the incidence of ventriculostomy related infections (VRIs) in patients who receive twenty-four hours of antibiotics, beginning no more than sixty minutes prior to EVD placement, to the incidence of VRIs in patients who also receive a pre-procedural dose of antibiotics with continued dosing of antibiotics for the duration of the external ventricular drain (EVD). At this time, the duration of prophylactic antibiotic use with antibiotic impregnated EVDs is unknown.
Conditions Studied
Interventions
- DRUG Long term (continuous) prophylactic antibiotics
- DRUG 24 hours antibiotics
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2021-06-14 |
| Est. Completion | 2026-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05001750
The ClinicalTrials.gov registry entry for NCT05001750 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,173-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (93% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Long term (continuous) prophylactic antibiotics is the first listed.
NCT05001750 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05001750 about?
NCT05001750 is a clinical study titled "Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?". The principal objective of this study is to compare the incidence of ventriculostomy related infections (VRIs) in patients who receive twenty-four hours of antibiotics, beginning no more than sixty minutes prior to EVD placement, to the incidence of VRIs in patients who also receive a pre-procedural...
What is the current status of trial NCT05001750?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 84 participants. The study started on 2021-06-14. Estimated completion is 2026-06.
What conditions does trial NCT05001750 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Hydrocephalus, Ventriculitis, Cerebral.
What interventions are being tested in trial NCT05001750?
The interventions under investigation include: Long term (continuous) prophylactic antibiotics (DRUG), 24 hours antibiotics (DRUG).
Who is sponsoring clinical trial NCT05001750?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05001750 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study
COMPLETED · Phase 1
-
Antihypertensive Treatment in Acute Cerebral Hemorrhage
COMPLETED · Phase 1
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RECRUITING · Phase 3
-
Transitions of Care for Stroke Patients
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.